Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 43 for “"WHO grade"”.
-
Seizures in WHO grade 2 glioma: semiology and significance
Background: WHO Grade 2 gliomas are a group of highly epileptogenic brain tumours. Seizures occur in the majority of patients and often at an early stage. How exactly these seizures are generated, their characteristics and their optimal management are not well understood. In addition, we also …
-
Investigation of molecular subtypes of WHO grade II-IV gliomas by use of T2 mapping sequences in Magnetic Resonance Imaging
… The revised World Health Organization (WHO) classification for tumors of the central nervous system, presented in 2016, included the molecular subtype of gliomas for the first time as this has a major influence on patient prognosis and response to therapy. It has been observed in several …
-
Stellenwert der Verlaufsbeobachtung, operativen Tumorresektion und Monochemotherapie bei Oligodendrogliomen WHO Grad II
INTRODUCTION Gliomas of histological WHO grades 2 and 3 show a heterogenous prognosis that largely depends on molecular tumor characteristics. Presence of 1p/19q codeletions distinguishes oligodendroglioma from astrocytoma among IDHmut gliomas. Both entities are associated with favourable outcome …
-
Stellenwert und Komplikationsraten stereotaktischer Probenentnahmen in der Gliomdiagnostik und -therapie
… patients diagnosed with IDH-mutant astrocytomas WHO grade 2 or 3 (n=183), either diagnosed by biopsy or resection, were further investigated for progression-free and overall survival. The cohort was stratified according to the postoperative strategy: wait-and-scan (n=98), radiotherapy (n=37) or …
-
An immunohistochemical analysis of the immune microenvironment in meningioma and its association with tumour recurrence
… reviewed and classified according to the 2016 WHO classification of central nervous system tumours. Demographic and tumour characteristics were summarised, and meningioma incidence estimated. Where sufficient archival tissue remained, tissue microarrays (TMAs) were constructed. Sections were …
-
Επιδημιολογική και ανοσολογική μελέτη ασθενών με γλοιώματα του ΚΝΣ
… of gliomas, and their association with the WHO grading system and Overall Survival. Material and Methods: We have conducted a case-control study of 49 patients with gliomas and 30 healthy controls referred to the University Hospital of Ioannina. Blood sample was undertaken preoperative. We …
-
Risk factors for haemorrhage in patients with haematological malignancies
… haemorrhage (World Health Organization (WHO) grade 2 or above bleeding) and up to 10% have severe or life-threatening haemorrhage (WHO grade 3 or 4 bleeding). Hence our current management of these patients to prevent haemorrhage is sub-optimal. The aim of this thesis was to identify …
-
Single-Voxel- versus Multi-Voxel-Protonen-MR-Spektroskopie bei verschiedenen intrakraniellen Läsionen
… bestehen. Untersucht wurden Hirntumoren der WHO-Grade 2 bis 4, Metastasen und fokal-entzündliche Läsionen. Zusammenfassend ist die Unterscheidung zwischen normalem und pathologisch verändertem Hirngewebe am besten mit der Singelvoxel-Methode und Bildung der CHO/CRE-Ratio möglich. Zur …
-
Functional Modelling of Heterogeneity in Paediatric Ependymoma
… is the third most common pediatric brain tumour whose underlying biology is poorly understood. The current therapeutic options are limited to gross total resection and radiotherapy, which carry limitations and toxic side effects. Ependymomas are classified based on where in the central nervous …
-
A systems approach to the different grades and progression of human astrocytoma
… from the least aggressive pilocytic astrocytoma (WHO grade 1) to the most aggressive glioblastoma (WHO grade 4). Molecular biomarkers or signatures—i.e., patterns of gene or protein expression that can reliably distinguish between each grade and provide insight into the underlying molecular events …
-
DEVELOPING STIMULI RESPONSIVE DEVICES FOR COMBINATION THERAPY TRIGGERED ADAPTIVE IMMUNITY AGAINST GLIOBLASTOMA
Glioblastoma (WHO grade IV), the most frequently occurring glioma in adults, with an incidence rate of 3.22 per 100,000, has dismal prognosis with the median survival of 12-15 months after diagnosis. . The current standard of care involves maximal safe resection followed by radiotherapy in …
-
Μελέτη των μηχανικών ιδιοτήτων των γλοιωμάτων εγκεφάλου σε χειρουργικά ιστοτεμάχια
… gliomas of different World Health Organization (WHO) grades, as well as the influence of histopathological traits and mechanical preconditioning on tumor and white matter elasticity. Methods: The elastic modulus was measured ex vivo on fresh tissue specimens acquired during craniotomy from the …
-
Μορφολογική μελέτη της έκφρασης των υποδοχέων κινάσης τυροσίνης Trks (υποδοχείς νευροτροφινών) και VEGFR-3 και συσχέτισή τους με την οδό μεταγωγής σήματος Epor/ JAK-2/ STAT-5 στους όγκους εγκεφάλου του ανθρώπου
… astrocytic gliomas: 5 pilocytic astrocytomas; WHO grade I, 6 diffuse fibrillary astrocytomas; WHO grade II, 10 anaplastic astrocytomas; WHO grade III and 29 glioblastomas multiforme; WHO grade IV, 8 oligodendrogliomas, 6 ependymomas, 5 medulloblastomas, and 23 meningiomas) were included in this …
-
USING STATISTICAL METHOD TO REVEAL BIOLOGICAL ASPECT OF HUMAN DISEASE: STUDY OF GLIOBLASTOMA BY USING COMPARATIVE GENOMIC HYBRIDIZATION (CGH) METHOD
Glioblastoma is a WHO grade IV tumor with high mortality rate. In order to identify the underlying biological causation of this disease, a comparative genomic hybridization dataset generated from 170 patients' tumor samples was analyzed. Of many available segmentation algorithms, I focused mainly …
-
The influence of host-derived osteopontin on glioma
Glioblastoma multiforme (WHO Grade IV) is the most common malignant neoplasm of the brain. Hallmarks of WHO grade IV designated tumors are a rapid pre- and postoperative disease evolution and a fatal outcome. Those features are also reflected in the low overall survival rate of GBM patients of …
-
Predicting Meningioma Recurrence Using Spectrochemical Analysis of Tissues and Subsequent Predictive Computational Algorithms
… nervous system (CNS) and are classified as WHO grades (1,2 ,&3) depending on histological sub-type, tumour growth rate and the likelihood of recurrence. The majority of meningioma are benign, yet, around 10% will recur following resection. Variation in follow-up of patients comes with …
-
Tissue Mechanics Govern Tumor Quiescence and Chemosensitivity in Medulloblastoma
… prevalent malignant brain tumor in children (WHO grade 4) that encompasses a heterogeneous group of cerebellar or brainstem embryonal tumors. Current standard-of-care is met with therapy resistance and associated with severe neurocognitive, neuroendocrine, and psychosocial side effects. …
-
The role of meningioma epigenetics in routine clinical practice
… μέχρι και σήμερα το σύστημα ταξινόμησης κατά WHO. Στην ανανεωμένη έκδοση κατά WHO ενσωματώνονται μοριακοί βιοδείκτες. Το προφίλ μεθυλίωσης των μηνιγγιωμάτων παρότι φάνηκε να είναι ένας αξιόπιστος προγνωστικός παράγοντας της υποτροπής και της πορείας των μηνιγγιωμάτων, δεν έχει ακόμη …
-
Biomarkers and predictors in glioblastoma recurrence
… diagnosed with glioblastoma (IDH-wildtype, grade 4) survive more than two years despite intense treatment. A crucial aspect of their rapid progression may lie in the tumors' ability to quickly form recurrences that become increasingly more aggressive and resistant to therapy. New ways to …
Page 1 of 3